Tenet Healthcare Future Growth

Future criteria checks 0/6

Tenet Healthcare's earnings are forecast to decline at 8% per annum while its annual revenue is expected to grow at 3.6% per year. EPS is expected to decline by 5.3% per annum. Return on equity is forecast to be 19.7% in 3 years.

Key information

-8.0%

Earnings growth rate

-5.3%

EPS growth rate

Healthcare earnings growth	16.2%
Revenue growth rate	3.6%
Future return on equity	19.7%
Analyst coverage	Good
Last updated	22 Apr 2024

Recent future growth updates

Recent updates

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Jan 31

Tenet Healthcare: Compressed Multiples Appear Justified

Jan 27

Tenet Health gains on on report David Einhorn's Greenlight has stake

Jan 17

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Jan 13

Tenet Healthcare: Earnings Headwinds With Mixed Technicals

Nov 11

Tenet Healthcare Q3 2022 Earnings Preview

Oct 19

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Oct 09

Tenet Healthcare: Mixed Debate, Rate Neutral On Valuation

Aug 25

Tenet Healthcare Q2 2022 Earnings Preview

Jul 20

Here's Why We Think Tenet Healthcare (NYSE:THC) Is Well Worth Watching

Jul 15

Earnings and Revenue Growth Forecasts

NYSE:THC - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	22,385	727	1,498	2,358	9
12/31/2025	21,256	602	1,705	2,213	17
12/31/2024	20,332	2,170	2,055	1,796	18
12/31/2023	20,548	611	1,623	2,374	N/A
9/30/2023	20,159	469	1,138	1,971	N/A
6/30/2023	19,894	499	961	1,783	N/A
3/31/2023	19,450	414	462	1,304	N/A
12/31/2022	19,174	410	321	1,083	N/A
9/30/2022	19,040	558	243	1,019	N/A
6/30/2022	19,133	875	414	1,136	N/A
3/31/2022	19,449	957	570	1,262	N/A
12/31/2021	19,485	915	910	1,568	N/A
9/30/2021	19,544	1,079	1,137	1,657	N/A
6/30/2021	19,207	434	1,323	1,818	N/A
3/31/2021	17,901	402	3,333	3,812	N/A
12/31/2020	17,640	399	2,867	3,407	N/A
9/30/2020	17,531	-18	2,929	3,481	N/A
6/30/2020	17,542	-48	2,685	3,307	N/A
3/31/2020	18,454	-112	692	1,352	N/A
12/31/2019	18,479	-226	563	1,233	N/A
9/30/2019	18,292	-228	258	963	N/A
6/30/2019	18,213	-10	197	882	N/A
3/31/2019	18,159	-10	280	946	N/A
12/31/2018	18,313	101	432	1,049	N/A
9/30/2018	18,672	-117	671	1,290	N/A
6/30/2018	18,769	-474	633	1,260	N/A
3/31/2018	19,065	-554	475	1,127	N/A
12/31/2017	19,179	-704	493	1,200	N/A
9/30/2017	19,061	-553	N/A	416	N/A
6/30/2017	19,324	-196	N/A	377	N/A
3/31/2017	19,390	-184	N/A	597	N/A
12/31/2016	19,621	-187	N/A	558	N/A
9/30/2016	19,787	-208	N/A	1,042	N/A
6/30/2016	19,630	-227	N/A	1,255	N/A
3/31/2016	19,254	-243	N/A	1,230	N/A
12/31/2015	18,634	-142	N/A	1,026	N/A
9/30/2015	18,073	19	N/A	1,054	N/A
6/30/2015	17,556	57	N/A	793	N/A
3/31/2015	17,101	107	N/A	649	N/A
12/31/2014	16,603	34	N/A	687	N/A
9/30/2014	16,023	-44	N/A	723	N/A
6/30/2014	14,256	-21	N/A	708	N/A
3/31/2014	12,641	-64	N/A	602	N/A
12/31/2013	11,087	-123	N/A	589	N/A
9/30/2013	9,548	-50	N/A	590	N/A
6/30/2013	9,361	-53	N/A	520	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: THC's earnings are forecast to decline over the next 3 years (-8% per year).

Earnings vs Market: THC's earnings are forecast to decline over the next 3 years (-8% per year).

High Growth Earnings: THC's earnings are forecast to decline over the next 3 years.

Revenue vs Market: THC's revenue (3.6% per year) is forecast to grow slower than the US market (7.9% per year).

High Growth Revenue: THC's revenue (3.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: THC's Return on Equity is forecast to be low in 3 years time (19.7%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Tenet Healthcare Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Consensus EPS estimates increase by 144%, revenue downgraded

Price target increased by 17% to US$104

Tenet Healthcare Corporation Provides Consolidated Earnings Guidance for the First Quarter and Full Year of 2024

Price target decreased by 7.4% to US$84.81

Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Recent updates

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Adventist Health System/West completed the acquisition of Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC).

UCI Medical Center acquired Fountain Valley Regional Hospital, Lakewood Regional Medical Center, Los Alamitos Medical, and Placentia-Linda Hospital from Tenet Healthcare Corporation (NYSE:THC).

Tenet Healthcare Corporation to Report Q1, 2024 Results on Apr 30, 2024

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Independent Director recently sold US$1.4m worth of stock

Independent Director notifies of intention to sell stock

Insider recently sold US$1.8m worth of stock

Chairman & CEO exercised options and sold US$2.3m worth of stock

Adventist Health System/West agreed to acquire Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC) for $550 million.

Independent Director recently sold US$715k worth of stock

New minor risk - Earnings quality

Consensus EPS estimates increase by 144%, revenue downgraded

Price target increased by 17% to US$104

Tenet Healthcare Corporation Provides Consolidated Earnings Guidance for the First Quarter and Full Year of 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Tenet Healthcare: Shrinking To Grow

Novant Health, Inc. completed the acquisition of Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) and Hilton Head Regional Healthcare, L.L.C.

Tenet Healthcare Corporation to Report Q4, 2023 Results on Feb 08, 2024

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Tenet Healthcare Corporation Appoints Vineeta Agarwala to Board of Directors, Member of the Quality, Compliance, and Ethics Committee

Independent Director recently sold US$400k worth of stock

Novant Health, Inc. signed a definitive agreement to acquire Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) for $2.4 billion.

Investor sentiment improves as stock rises 18%

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Price target decreased by 7.4% to US$84.81

Third quarter 2023 earnings: EPS misses analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Tenet Healthcare Corporation to Report Q3, 2023 Results on Oct 30, 2023

Tenet Healthcare Corporation Announces Retirement of Daniel Cancelm as Executive Vice President, Effective December 31, 2023

Tenet Healthcare Corporation Appoints Senator Roy Blunt to Board of Directors

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Tenet Healthcare Corporation to Report Q2, 2023 Results on Jul 31, 2023

Insider notifies of intention to sell stock

Tenet Healthcare Corporation Appoints Stephen H. Rusckowski to its Board of Directors

EVP, Chief Administrative Officer recently sold US$1.5m worth of stock

EVP, Chief Administrative Officer notifies of intention to sell stock

Tenet Healthcare Corporation announced that it expects to receive $1.35 billion in funding

Price target increased by 11% to US$82.32

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

EVP, Chief Administrative Officer recently sold US$96k worth of stock

Independent Director notifies of intention to sell stock

Price target increased by 7.6% to US$71.65

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the First Quarter and Full Year of 2023

USPI and Providence extend hands to aid ambulatory surgical services

Now 21% undervalued

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Compressed Multiples Appear Justified

Tenet Healthcare Corporation Announces Management Changes

Tenet Healthcare Corporation to Report Q4, 2022 Results on Feb 09, 2023

Tenet Health gains on on report David Einhorn's Greenlight has stake

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Now 22% undervalued after recent price drop

Tenet Healthcare: Earnings Headwinds With Mixed Technicals

CFO & Executive VP recently bought US$474k worth of stock

Investor sentiment deteriorated over the past week

Price target decreased to US$73.12

Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Tenet Healthcare Corporation (NYSE:THC) announces an Equity Buyback for $1,000 million worth of its shares.

Tenet Healthcare Q3 2022 Earnings Preview

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?